No Data
No Data
Rodman & Renshaw Initiates Alto Neuroscience(ANRO.US) With Buy Rating, Announces Target Price $43
Rodman & Renshaw analyst Elemer Piros initiates coverage on $Alto Neuroscience(ANRO.US)$ with a buy rating, and sets the target price at $43.According to TipRanks data, the analyst has a success rate
Alto Neuroscience Initiated at Buy by Rodman & Renshaw
Alto Neuroscience Initiated at Buy by Rodman & Renshaw
Express News | Rodman & Renshaw Initiates Coverage On Alto Neuroscience With Buy Rating, Announces Price Target of $43
Alto Neuroscience Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/21/2024 273.26% Rodman & Renshaw → $43 Initiates Coverage On → Buy 03/25/2024 177.78% Stifel → $32 Reit
Express News | Alto Neuroscience Initiates Phase 2 Study Of ALTO-101 For Cognitive Impairment Associated With Schizophrenia
Express News | Alto Neuroscience Inc: Expects to Report Top-Line Data From Phase 2 Study in Second Half of 2025
No Data